MedKoo Cat#: 599051 | Name: LJ 1121

Description:

WARNING: This product is for research use only, not for human or veterinary use.

LJ 1121 is a bioactive chemical.

Chemical Structure

LJ 1121
CAS#67932-00-7

Theoretical Analysis

MedKoo Cat#: 599051

Name: LJ 1121

CAS#: 67932-00-7

Chemical Formula: C14H19BrF4N2O2

Exact Mass:

Molecular Weight: 403.21

Elemental Analysis: C, 41.70; H, 4.75; Br, 19.82; F, 18.85; N, 6.95; O, 7.94

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
LJ 1121; LJ-1121 LJ1121
IUPAC/Chemical Name
3-(4-(4-fluoro-3-(trifluoromethyl)phenyl)piperazin-1-yl)propane-1,2-diol hydrobromide
InChi Key
OSHLWKGKTBBTIA-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H18F4N2O2.BrH/c15-13-2-1-10(7-12(13)14(16,17)18)20-5-3-19(4-6-20)8-11(22)9-21;/h1-2,7,11,21-22H,3-6,8-9H2;1H
SMILES Code
OCC(O)CN1CCN(C2=CC=C(F)C(C(F)(F)F)=C2)CC1.[H]Br
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 403.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Been JV, Mackenbach JP, Millett C, Basu S, Sheikh A. Tobacco control policies and perinatal and child health: a systematic review and meta-analysis protocol. BMJ Open. 2015 Sep 22;5(9):e008398. doi: 10.1136/bmjopen-2015-008398. Review. PubMed PMID: 26399572; PubMed Central PMCID: PMC4593151. 2: Peelen MJ, Sheikh A, Kok M, Hajenius P, Zimmermann LJ, Kramer BW, Hukkelhoven CW, Reiss IK, Mol BW, Been JV. Tobacco control policies and perinatal health: a national quasi-experimental study. Sci Rep. 2016 Apr 22;6:23907. doi: 10.1038/srep23907. PubMed PMID: 27103591; PubMed Central PMCID: PMC4840332. 3: Potokar M, Jorgačevski J, Zorec R. Astrocyte Aquaporin Dynamics in Health and Disease. Int J Mol Sci. 2016 Jul 13;17(7). pii: E1121. doi: 10.3390/ijms17071121. Review. PubMed PMID: 27420057; PubMed Central PMCID: PMC4964496. 4: Allen ST, Ruiz MS, Jones J, Turner MM. Legal space for syringe exchange programs in hot spots of injection drug use-related crime. Harm Reduct J. 2016 Apr 26;13:16. doi: 10.1186/s12954-016-0104-3. PubMed PMID: 27112328; PubMed Central PMCID: PMC4845437. 5: Yoder KM, Edelstein BL. Oral health policy forum: developing dental student knowledge and skills for health policy advocacy. J Dent Educ. 2012 Dec;76(12):1572-9. PubMed PMID: 23225676. 6: Mackin ML, Clark K. Emergency contraception in Iowa pharmacies before and after over-the-counter approval. Public Health Nurs. 2011 Jul-Aug;28(4):317-24. doi: 10.1111/j.1525-1446.2011.00951.x. Epub 2011 Apr 15. PubMed PMID: 21736610. 7: Moodie C, MacKintosh AM, Brown A, Hastings GB. Tobacco marketing awareness on youth smoking susceptibility and perceived prevalence before and after an advertising ban. Eur J Public Health. 2008 Oct;18(5):484-90. doi: 10.1093/eurpub/ckn016. Epub 2008 Mar 24. PubMed PMID: 18362094. 8: Brown A, Moodie C. The influence of tobacco marketing on adolescent smoking intentions via normative beliefs. Health Educ Res. 2009 Aug;24(4):721-33. doi: 10.1093/her/cyp007. Epub 2009 Mar 13. PubMed PMID: 19286895. 9: Bragadóttir H. Children's rights in clinical research. J Nurs Scholarsh. 2000;32(2):179-84. Review. PubMed PMID: 10887718. 10: Coates J. Blowing the whistle on bad practice. N Z Med J. 2000 Nov 10;113(1121):473. PubMed PMID: 11194756. 11: Street D, Quadagno J, Parham L, McDonald S. Reinventing long-term care: the effect of policy changes on trends in nursing home reimbursement and resident characteristics--Florida, 1989-1997. Gerontologist. 2003 Apr;43 Spec No 2:118-31. PubMed PMID: 12711732. 12: Averhoff FM, Williams WW, Hadler SC. Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. J Sch Health. 1997 Sep;67(7):298-303. PubMed PMID: 9358390. 13: Starck SÅ, Rosendahl L. Evaluation and optimization of administered activity, scanning parameters and hydration at (99m) Tc hydroxymethylene diphosphonate adult whole-body bone imaging. Clin Physiol Funct Imaging. 2012 Nov;32(6):431-6. doi: 10.1111/j.1475-097X.2012.01145.x. Epub 2012 Jun 14. PubMed PMID: 23031063. 14: Toebes B, Gispen ME, Been JV, Sheikh A. A missing voice: the human rights of children to a tobacco-free environment. Tob Control. 2018 Jan;27(1):3-5. doi: 10.1136/tobaccocontrol-2017-053657. Epub 2017 Jul 12. PubMed PMID: 28701584; PubMed Central PMCID: PMC5801650.